Paul F.

Paul F. is a seasoned professional in the field of computational chemistry and drug discovery, currently serving as CEO and Co-Founder of Elixir Software Ltd since June 2012. With over 70 years of collective industry experience from founding members, Elixir Software specializes in enhancing collaborations between pharmaceutical, biotech companies, and research organizations. Prior to this, Paul F. held positions as a Computational Chemist at AstraZeneca, focusing on oncology, and at GlaxoSmithKline, specializing in inflammatory diseases. Paul F. also contributed to molecular design at Tularik, working on inflammation and oncology projects. Paul F. holds a Doctor of Philosophy (PhD) in Computational Chemistry from The University of Manchester.